Unlock instant, AI-driven research and patent intelligence for your innovation.
Heterocyclic compound, and p27 kip1 degradation inhibitor
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound and heterocyclic technology, applied in the field of heterocyclic compounds and p27Kip1 decomposition inhibitors, can solve problems such as undocumented relationships
Active Publication Date: 2013-03-20
ASKA PHARMACEUTICAL CO LTD
View PDF5 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, its relationship with intracellular proteins is not documented
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1-1
[0324] Step 1-1-1
[0325] Ethyl 4-fluoro-3-nitrobenzoate
[0326] [chem 30]
[0327]
[0328] Suspend 4-fluoro-3-nitrobenzoic acid (150g, 0.810mol) in ethanol (1000ml), add concentrated sulfuric acid (25ml) dropwise, and heat to reflux for 8 hours. After standing to cool, it was concentrated under reduced pressure, and water was added with stirring. The precipitate was separated by filtration, washed with water and ventilated to dry to obtain the title compound (160 g, 93%) as a yellow solid.
[0335] Dissolve ethyl 4-fluoro-3-nitrobenzoate (10.0 g, 46.9 mmol) prepared in the above step 1-1-1 in methanol (40 ml), add triethylamine (10 ml, 70.4 mmol), an...
Embodiment 1-2～1-6
[0360] Instead of the 40% methylamine-methanol solution as the ring-forming component, or ethyl 4-fluoro-3-nitrobenzoate as the monocyclic compound, the compounds shown in the table below were used. 1-1 is operated in the same way to obtain the target bicyclic compound.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
Provided are a novel heterocyclic compound and salt thereof applicable in the selective inhibition of the degradation of p27Kip1. The compound and the salt thereof are represented in formula (1). [In the formula: A represents an alkyl group, a cycloalkyl group, an aryl group, or a heterocyclic group, and group A can have a substituent group; ring B represents a 5- to 8- membered monocyclic heterocyclic ring or a condensed ring containing this monocyclic heterocyclic ring, and ring B can have a substituent group; ring C represents an aromatic ring, and ring C can have a substituent group; L represents a linker having 3-5 atoms in the main chain selected from carbon atoms, nitrogen atoms, oxygen atoms, and sulfur atoms, and having at least one heteroatom selected from nitrogen atoms, oxygen atoms, and sulfur atoms, and linker L can have a substituent group; and n represents 0 or 1.]
Description
technical field [0001] The present invention relates to a heterocyclic compound that specifically binds ubiquitinproteinkinase (SCF Skp2 ), the constituent protein Skp2, for example inhibits the release from SCF Skp2 p27 in complex Kip1 dissociates, and consequently, inhibits p27 Kip1 Proceeding of ubiquitination and simultaneous inhibition of p27 induced by the proteasome Kip1 The decomposition of the present invention also relates to the p27 containing the compound Kip1 ubiquitination inhibitor (or p27 Kip1 decomposition inhibitors), and prophylactic and / or therapeutic agents (for example, anticancer agents) for cell proliferative diseases. Background technique [0002] p27 Kip1 is a cyclin-dependent kinase inhibitor (CDK inhibitor) that acts as a factor that negatively regulates cell cycle progression. According to clinical studies, in highly malignant cancer cells due to p27 Kip1 hyperlysis of p27 Kip1 expression decreased. In addition, it is revealed that th...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More